Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide Peptide Therapy: A New Era in Appetite Control and Weight Revolution Health & Wellness Beautyholic Meet Zephregine (Cagrilintide): The Next Generation Metabolic Peptide A breakthrough in weight management, designed to work with your body, not against it. BENEFITS Weight Loss & Body Composition